A SARS-CoV-2 mutant from B.1.258 lineage with ∆H69/∆V70 deletion in the Spike protein circulating in Central Europe in the fall 2020
- PMID: 34448987
- PMCID: PMC8390540
- DOI: 10.1007/s11262-021-01866-5
A SARS-CoV-2 mutant from B.1.258 lineage with ∆H69/∆V70 deletion in the Spike protein circulating in Central Europe in the fall 2020
Abstract
SARS-CoV-2 mutants carrying the ∆H69/∆V70 deletion in the amino-terminal domain of the Spike protein emerged independently in at least six lineages of the virus (namely, B.1.1.7, B.1.1.298, B.1.160, B.1.177, B.1.258, B.1.375). We analyzed SARS-CoV-2 samples collected from various regions of Slovakia between November and December 2020 that were presumed to contain B.1.1.7 variant due to drop-out of the Spike gene target in an RT-qPCR test caused by this deletion. Sequencing of these samples revealed that although in some cases the samples were indeed confirmed as B.1.1.7, a substantial fraction of samples contained another ∆H69/∆V70 carrying mutant belonging to the lineage B.1.258, which has been circulating in Central Europe since August 2020, long before the import of B.1.1.7. Phylogenetic analysis shows that the early sublineage of B.1.258 acquired the N439K substitution in the receptor-binding domain (RBD) of the Spike protein and, later on, also the deletion ∆H69/∆V70 in the Spike N-terminal domain (NTD). This variant was particularly common in several European countries including the Czech Republic and Slovakia but has been quickly replaced by B.1.1.7 early in 2021.
Keywords: B.1.1.7; B.1.258; Deletion; SARS-CoV-2; Spike; Variant.
© 2021. The Author(s).
Conflict of interest statement
MultiplexDX, s.r.o. has developed and manufactured the B.1.1.7 differential RT-qPCR assay kit. Biomedical Research Center of the Slovak Academy of Sciences has entered into collaboration with MultiplexDX, s.r.o. for development and validation of RT-qPCR tests. All other authors declare no competing interests.
Figures

References
-
- Volz E, Mishra S, Chand M, Barrett JC, Johnson R, Geidelberg L, et al (2020) Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data. medRxiv [Preprint].10.1101/2020.12.30.20249034
-
- Washington NL, White S, Schiabor Barrett KM, Cirulli ET, Bolze A, Lu JT, et al (2020) S gene dropout patterns in SARS-CoV-2 tests suggest spread of the H69del/V70del mutation in the US. medRxiv [Preprint]. 10.1101/2020.12.24.20248814
-
- Bal A, Destras G, Gaymard A, Stefic K, Marlet J, Eymieux S, et al. Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020. Euro Surveill. 2021 doi: 10.2807/1560-7917.ES.2021.26.3.2100008. - DOI - PMC - PubMed
-
- Borges V, Sousa C, Menezes L, Gonçalves AM, Picão M, Almeida JP, et al (2021) Tracking SARS-CoV-2 VOC 202012/01 (lineage B.1.1.7) dissemination in Portugal: insights from nationwide RT-PCR Spike gene drop out data. virological.org. Available from: https://virological.org/t/tracking-sars-cov-2-voc-202012-01-lineage-b-1-... - PMC - PubMed
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous